Abbott Laboratories buy Royal Bank of Canada
Start price
25.01.24
/
50%
€102.54
Target price
25.01.25
€118.09
Performance (%)
-6.06%
Price
24.05.24
€95.81
Summary
This prediction is currently active. With a performance of -6.06%, the BUY prediction for Abbott Laboratories by Royal_Bank_of_Canada is down slightly. A total of €0.52 was paid as dividends for this prediction. This prediction currently runs until 25.01.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Abbott Laboratories | 0.063% | 0.063% |
iShares Core DAX® | -0.205% | 2.949% |
iShares Nasdaq 100 | 1.613% | 5.877% |
iShares Nikkei 225® | -0.740% | -1.256% |
iShares S&P 500 | 0.267% | 3.240% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $128.00 price target on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€98.67
19.04.24
19.04.24
€117.41
19.04.25
19.04.25
-2.90%
24.05.24
24.05.24
Abbott Laboratories
Start price
Target price
Perf. (%)
€104.16
14.02.24
14.02.24
€119.35
14.02.25
14.02.25
-7.52%
24.05.24
24.05.24
Abbott Laboratories
Start price
Target price
Perf. (%)
€102.98
11.01.24
11.01.24
€116.90
11.01.25
11.01.25
-5.97%
24.05.24
24.05.24